Metaproteomics Reveals Potential Mechanisms by which Dietary Resistant Starch Supplementation Attenuates Chronic Kidney Disease Progression in Rats

Autor: Yasir Rahmatallah, Alan J. Tackett, Oleg Karaduta, Stephanie D. Byrum, Dorothy A. Kieffer, Dmitri S. Andreyev, Taylor McElroy, Roy J. Martin, Sean H. Adams, Nosratola D. Vaziri, Lisa M. Orr, Boris Zybailov, John M. Arthur, Galina V. Glazko, Ricky D. Edmondson, Samuel G. Mackintosh

Publikováno v: PLoS ONE
Zybailov, Boris L; Glazko, Galina V; Rahmatallah, Yasir; Andreyev, Dmitri S; McElroy, Taylor; Karaduta, Oleg; et al.(2019). Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats.. PloS one, 14(1), e0199274. doi: 10.1371/journal.pone.0199274. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/5zp1p5gf
PLoS ONE, Vol 14, Iss 1, p e0199274 (2019)
PloS one, vol 14, iss 1

BackgroundResistant starch is a prebiotic metabolized by the gut bacteria. It has been shown to attenuate chronic kidney disease (CKD) progression in rats. Previous studies employed taxonomic analysis using 16S rRNA sequencing and untargeted metabolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457647ed60a9fe0cca07f11a17ef8639